Company intelligence / Profile preview

Relyens

Lyon, Auvergne-Rhone-Alpes, France

Ownership: Private
Employees: ~1200
Development stage: Other

Overview

Relyens does not operate as a clinical-stage biotech or pharma company, so conventional clinical results and pipelines are not applicable. It is the leading European mutual group specializing in risk management services, particularly for healthcare and local authorities. The company focuses on integrating risk management, tech-driven solutions, and insurance to anticipate, prevent, and insure against risks impacting health and public sector organizations[1][2][3].

Industry: Consulting

Beyond the preview

Go deeper on Relyens.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Relyens.

Explore the full profile